Author:
Wang Liang,Wang Hua,Xia Zhong-Jun,Huang Hui-Qiang,Jiang Wen-Qi,Lin Tong-Yu,Lu Yue
Publisher
Springer Science and Business Media LLC
Subject
Hematology,General Medicine
Reference36 articles.
1. Said J, Lones M, Yea S (2014) Burkitt lymphoma and MYC: what else is new? Adv Anat Pathol 21(3):160–165. doi: 10.1097/PAP.0b013e3182a92cde
2. Jacobson C, LaCasce A (2014) How I treat Burkitt lymphoma in adults. Blood 124(19):2913–2920. doi: 10.1182/blood-2014-06-538504
3. Wasterlid T, Brown PN, Hagberg O, Hagberg H, Pedersen LM, D’Amore F, Jerkeman M (2013) Impact of chemotherapy regimen and rituximab in adult Burkitt lymphoma: a retrospective population-based study from the Nordic Lymphoma Group. Ann Oncol Off J Eur Soc Med Oncol/ESMO 24(7):1879–1886. doi: 10.1093/annonc/mdt058
4. Rowe M, Fitzsimmons L, Bell AI (2014) Epstein-Barr virus and Burkitt lymphoma. Chin J Cancer 33(12):609–619. doi: 10.5732/cjc.014.10190
5. Satou A, Asano N, Nakazawa A, Osumi T, Tsurusawa M, Ishiguro A, Elsayed AA, Nakamura N, Ohshima K, Kinoshita T, Nakamura S (2014) Epstein-Barr virus (EBV)-positive sporadic Burkitt lymphoma: an age-related lymphoproliferative disorder? Am J Surg Pathol. doi: 10.1097/PAS.0000000000000332